glycyl- glycyl- alanyl- glycyl- cysteinyl- (PEG)4- cysteinyl- adrenomedullin (22-52)

an adrenomedullin receptor ligand for imaging pulmonary circulation

Also Known As:

adrenomedullin (22-52), glycyl-glycyl-alanyl-glycyl-cysteinyl-(PEG)4-cysteinyl-; Gly-Gly-d-Ala-Gly-Cys-d-(PEG)4-Cys-hAM(22-52); PulmoBind; adrenomedullin (22-52), Gly-Gly-Ala-Gly-Cys-(PEG)4-Cys-

Networked: 4 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Dupuis, Jocelyn: 4 articles (01/2019 - 01/2015)
2.	Fournier, Alain: 4 articles (01/2019 - 01/2015)
3.	Harel, François: 4 articles (01/2019 - 01/2015)
4.	Finnerty, Vincent: 3 articles (07/2017 - 01/2015)
5.	Levac, Xavier: 3 articles (07/2017 - 01/2015)
6.	Nguyen, Quang T: 3 articles (07/2017 - 01/2015)
7.	Letourneau, Myriam: 2 articles (01/2019 - 07/2017)
8.	Cossette, Mariève: 2 articles (05/2015 - 01/2015)
9.	Létourneau, Myriam: 2 articles (05/2015 - 01/2015)
10.	Marcil, Sophie: 2 articles (05/2015 - 01/2015)

Related Diseases

1.	Pulmonary Hypertension 05/01/2015 - "In preclinical studies, PulmoBind scans enabled detection of lung perfusion defects and quantification of microcirculatory occlusion caused by pulmonary hypertension. " 01/01/2015 - "In preclinical studies, PulmoBind scans enabled detection of lung perfusion defects and quantification of microcirculatory occlusion caused by pulmonary hypertension. " 07/01/2017 - "We evaluated the safety of PulmoBind SPECT imaging and its capacity to detect pulmonary vascular disease associated with pulmonary hypertension (PH) in a human phase II study. " 01/01/2019 - "PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension."
2.	Vascular Diseases (Vascular Disease) 07/01/2017 - "We evaluated the safety of PulmoBind SPECT imaging and its capacity to detect pulmonary vascular disease associated with pulmonary hypertension (PH) in a human phase II study. " 07/01/2017 - "PulmoBind showed potential to detect both pulmonary embolism and abnormalities indicative of pulmonary vascular disease in PAH. " 07/01/2017 - "PulmoBind, an adrenomedullin receptor ligand, was developed for molecular diagnosis of pulmonary vascular disease. "
3.	Pulmonary Embolism 07/01/2017 - "PulmoBind showed potential to detect both pulmonary embolism and abnormalities indicative of pulmonary vascular disease in PAH. "

Related Drugs and Biologics

1.	Adrenomedullin Receptors
2.	Ligands
3.	Sildenafil Citrate (Viagra)